CRBRX
Price
$12.84
Change
-$0.01 (-0.08%)
Updated
Jun 20 closing price
Net Assets
2.39B
PMAQX
Price
$45.65
Change
+$0.08 (+0.18%)
Updated
Jun 18 closing price
Net Assets
30.52B
Interact to see
Advertisement

CRBRX vs PMAQX

Header iconCRBRX vs PMAQX Comparison
Open Charts CRBRX vs PMAQXBanner chart's image
Columbia Acorn Inst2
Price$12.84
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets2.39B
Principal MidCap R6
Price$45.65
Change+$0.08 (+0.18%)
VolumeN/A
Net Assets30.52B
CRBRX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CRBRX vs. PMAQX commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBRX is a Hold and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30.5B vs. CRBRX (2.39B). PMAQX pays higher dividends than CRBRX: PMAQX (0.19) vs CRBRX (0.00). CRBRX was incepted earlier than PMAQX: CRBRX (13 years) vs PMAQX (9 years). CRBRX (0.81) is less costly to investors than PMAQX (0.59). CRBRX is a more actively managed with annual turnover of: 81.00 vs. PMAQX (10.50). CRBRX (0) and PMAQX (0) have matching initial minimum investment requirements. PMAQX annual gain was more profitable for investors over the last year : 9.74 vs. CRBRX (4.30). PMAQX return over 5 years is better than : 54.65 vs. CRBRX (-14.15).
CRBRXPMAQXCRBRX / PMAQX
Total Expense Ratio0.780.59132%
Annual Report Gross Expense Ratio0.810.59137%
Fund Existence13 years9 years-
Gain YTD-6.9512.285-304%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.39B30.5B8%
Annual Yield % from dividends0.000.19-
Returns for 1 year4.309.7444%
Returns for 3 years40.1354.0374%
Returns for 5 years-14.1554.65-26%
Returns for 10 years-61.60N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COYA5.510.19
+3.57%
Coya Therapeutics
ATGE124.501.59
+1.29%
Adtalem Global Education
ESPR1.100.01
+0.92%
Esperion Therapeutics
EPAM165.02-3.56
-2.11%
Epam Systems
TNFA0.14-0.01
-6.68%
TNF Pharmaceuticals Inc.